New CPAP strategy aims to help preterm lungs grow stronger
NCT ID NCT06123143
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests a structured plan for slowly removing breathing support (CPAP) from preterm infants born before 30 weeks. The goal is to see if keeping babies on CPAP until a specific age reduces breathing problems and lung damage. About 130 infants will be randomly assigned to either the structured plan or standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- structured CPAP weaning protocol
- What this could lead to
- If successful, this could establish a better way to wean preterm infants off breathing support, potentially reducing chronic lung disease and hospital stays.
- What could go wrong
- This is a relatively small, early-stage study (130 infants) comparing a structured protocol to standard care. Results may not apply to all hospitals or infants, and the protocol may not reduce weaning failure as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL RESPIRATORY FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Palomar Medical Center Rady NICU
RECRUITINGEscondido, California, 92029, United States
-
Rady Children's Hospital-San Diego
RECRUITINGSan Diego, California, 92123, United States
-
Rancho Springs Medical Center Rady NICU
RECRUITINGMurrieta, California, 92562, United States
-
Scripps La Jolla Rady NICU
RECRUITINGLa Jolla, California, 92037, United States
-
University of California, San Diego Jacobs Medical Center
RECRUITINGLa Jolla, California, 92037, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.